• Users Online: 110
  • Print this page
  • Email this page
REVIEW ARTICLE
Year : 2020  |  Volume : 7  |  Issue : 3  |  Page : 148-154

Human vaccines industry in China, 2019: Part III


Ex-Adviser, Department of Biotechnology, Ministry of Science and Technology, Government of India, New Delhi, India

Correspondence Address:
Dr. Prasanta Kumar Ghosh
Department of Biotechnology, Government of India; BlockC2B, Flat 5A, Janakpuri, New Delhi, Delhi.
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/mgmj.mgmj_51_20

Rights and Permissions

There are five multinational companies (MNCs), operating in China in the vaccine field. These companies have made a sizable investment in China on various counts, including the establishment of local offices, teaming up with certain Chinese companies, and some have also made a sizable investment in R&D for pursuing both basic types of research as well as application-oriented research and/or manufacturing or repacking facilities. The MNCs sell their proprietary vaccines either directly or have teamed up with Chinese companies for sale.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed146    
    Printed7    
    Emailed1    
    PDF Downloaded30    
    Comments [Add]    

Recommend this journal